Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms-Reference-Cited by-同舟云学术

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Published:2017-10-13 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Carhart-Harris Robin L,Roseman Leor,Bolstridge Mark,Demetriou Lysia,Pannekoek J Nienke,Wall Matthew B,Tanner Mark,Kaelen Mendel,McGonigle John,Murphy Kevin,Leech Robert,Curran H Valerie,Nutt David J

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-13282-7.pdf

Reference67 articles.

1. Carhart-Harris, R. L. & Goodwin, G. M. The Therapeutic Potential of Psychedelic Drugs: Past, Present and Future. Neuropsychopharmacology, https://doi.org/10.1038/npp.2017.84 (2017).

2. Watts, R. D., Krzanowski, C, Nutt, J. D. & Carhart-Harris, R, L. Patients’ accounts of increased ‘connection’ and ‘acceptance’ after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology (2017).

3. Grob, C. S. et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 68, 71–78, https://doi.org/10.1001/archgenpsychiatry.2010.116 (2011).

4. Griffiths, R. R. et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of psychopharmacology 30, 1181–1197, https://doi.org/10.1177/0269881116675513 (2016).

5. Ross, S. et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of psychopharmacology 30, 1165–1180, https://doi.org/10.1177/0269881116675512 (2016).

Cited by 370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotonergic neuromodulation of synaptic plasticity;Neuropharmacology;2024-10

2. A bibliometric analysis of research on psychedelics for depression treatment;Heliyon;2024-09

3. The Therapeutic Potential of Psychedelics on Reducing Rumination: A Mini-Review;Psychedelic Medicine;2024-09-01

4. The role of psilocybin in depressive disorders;Current Medical Research and Opinion;2024-08-28

5. The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting;2024-08-26